“…Based on the reported SAR of fluoroquinolones , and on our work, , we set out to design and synthesize novel N 4-substituted piperazinyl derivatives of norfloxacin in an attempt to improve its potency and possibly enable new target interactions. Guided by a primary molecular docking study, a broad range of diverse aliphatic, cyclic, aromatic, and heterocyclic substituents were selected, including aliphatic amines, anilines, and nitrogen-containing heterocycles such as aminothiazoles, isatin, quinazolinones, imidazoles, triazoles, oxadiazoles, benzohydrazides, and isoniazid, which were added to norfloxacin using N -acetyl, thioacetyl, or methylene linkers (Figure ).…”